Ajinomoto’s miss is not a food demand story, it is an ABF optionality story hiding inside a cheap-looking disappointment

The print means the stock should be debated less as a consumer staples earnings miss and more as a semiconductor materials capacity and mix asset whose food-cycle noise obscured the most investable signal. What was priced in was a cleaner quarter: the street modeled revenue of ¥392,730.7 million and EPS of ¥32.01, which implied investors expected Ajinomoto to hold the line after Q1 FY2026 revenue of ¥364,008.0 million and gross margin of 38.2%. What actually surprised was the size and composition of the shortfall: revenue came in at ¥374,873.0 million, a -4.5% surprise, and EPS came in at ¥19.56, a -38.9% surprise, even though revenue still grew +3.0% QoQ from Q1 FY2026. That combination, sequential revenue recovery with an EPS miss, is why this is not a simple top-line disappointment. The market can sell the miss, but the more useful question is whether the earnings shortfall is coming from the businesses investors should capitalize, or from the businesses investors should look through.

The financial trajectory argues for looking through part of the miss, because the gross-margin path is materially better than the EPS line suggests. Q2 FY2026 gross margin was 37.5%, down from Q1 FY2026 at 38.2%, but still above Q2 FY2025 at 36.4% and above Q4 FY2025 at 33.9%. Revenue of ¥374,873.0 million was -1.0% YoY against Q2 FY2025 revenue of ¥378,742.0 million, so the company did not earn its margin by riding a broad sales acceleration. The market expected ¥392,730.7 million of revenue, but the reported margin tells a different story from the revenue miss: mix and pricing are doing more work than volume. That is exactly what management’s first-half bridge says in its own accounts, where sales were ¥738.8 billion and “nearly unchanged year-on-year,” while profit attributable to owners of the parent company increased 2% from the previous year. The mismatch between the street-comparison basis and management’s first-half basis should not be blended into one figure, but the direction is consistent: reported demand is not clean, yet gross profit quality is better than a -38.9% EPS surprise implies.

That margin resilience matters because the food businesses are showing a pricing-led defense rather than a volume-led recovery. In Japan first-half sales were 107% year before, but volume was 94% and unit price was 113%, a spread that says the consumer is accepting price only at the cost of units. Management added that Japanese Food Products excluding coffee reached 101% in overall sales with volume at 99% and unit price at 102%, which is a narrower but still pricing-heavy result. Overseas sales increased to 103% versus the previous year, so international food is not collapsing, but it is not strong enough to offset the domestic volume message. The market was right to price in some operating resilience after Q1 FY2026 gross margin of 38.2%, and wrong if it assumed that resilience would come from broad volume. What surprised negatively was that the company’s Q2 FY2026 EPS of ¥19.56 did not follow the gross-margin defense; what surprised positively, and is easier to miss, is that the Food Products issue looks like mix and consumer elasticity, not a failure to price raw-material pressure.

The capacity story explains why the semiconductor read-through deserves a higher weight than the reported EPS miss, because management’s language around Functional Materials is not casual cycle commentary. Shigeo Nakamura said, “At the same time, amid positive market conditions, both sales and business profit in the Functional Materials grew to 120% of the previous year's levels in the first half.” The wording matters because it ties both sales and business profit, not just shipments, to the cycle. That is the core variant perception: ABF is not just contributing revenue; it is contributing profit leverage at the moment when food volume is mixed. The call also referenced calendar-year logic IC growth of plus 23.9%, and Nakamura said he thought “we are close to 20% growth is already shown here.” Those numbers align with the customer map: ABF insulating film and substrate film exposure touches Ibiden, TSMC, Intel, Samsung, Unimicron, Nan Ya PCB, Simmtech, Compeq Manufacturing, ASE Group, and ZACROS. If Ajinomoto’s Functional Materials sales and business profit are already at 120% of prior-year first-half levels, the implication for those packaging-substrate and advanced-packaging customers is that ABF availability and pricing are not behaving like a weak electronics chemical channel.

That customer read-through is especially important for substrate names because Ajinomoto’s strategy appears to be shifting control of value capture rather than merely chasing outside demand. Yoshiteru Masai said, “So in the long term, this internal sales proportion of 70% is going to be raised to more than 85% by 2030.” The commitment embedded in that sentence is not about one quarter; it is about where Ajinomoto wants the economics of ABF to sit over the next capital cycle. For Ibiden, Unimicron, Nan Ya PCB, Simmtech, and Compeq Manufacturing, a move from 70% to more than 85% internal sales proportion by 2030 means Ajinomoto is thinking about channel architecture and capture, not merely shipment recovery. For TSMC, Intel, Samsung, and ASE Group, the first-half 120% Functional Materials signal says the packaging material bottleneck is moving with logic demand rather than waiting for a generalized industrial recovery. ZACROS, named as ABF resin varnish toll coating exposure, is the one listed supplier-side read-through in the pack; the internal-sales target above 85% by 2030 is the number to monitor for whether toll coating remains capacity support or becomes strategically more constrained.

The competitive point is that Ajinomoto’s reported quarter does not screen like the broad materials peer set, and that difference is exactly why the miss can be mispriced. Q2 FY2026 revenue YoY was -1.0% and gross margin was 37.5%; in the peers table, 6367.T has revenue YoY of +16.4% with gross margin of 32.9%, 4901.T has revenue YoY of +6.8% with gross margin of 40.6%, and 4188.T has revenue YoY of -10.1% with gross margin of 29.9%. Ajinomoto is not the fastest grower in that set, and the revenue miss versus ¥392,730.7 million confirms it should not be bought on broad revenue momentum. But the 37.5% gross margin sits much closer to the high-quality end represented by 4901.T at 40.6% than to 4188.T at 29.9% or 4005.T at 22.4%. That margin position, combined with the Functional Materials 120% first-half growth language, supports a sum-of-parts view in which the market may be over-penalizing consumer volume weakness and under-capitalizing semiconductor materials.

The tone of the call reinforces that interpretation, with one caveat: management sounded more confident than in Q1 FY2026, but not uniformly more promotional. The tone history shows sentiment rising from 0.11 in Q1 FY2026 to 0.23 in Q2 FY2026, tone_confidence moving from 0.38 to 0.63, and qa_sentiment moving from 0.16 to 0.26. At the same time, guidance_tone fell from 0.49 to 0.33 and ai_optimism fell from 0.91 to 0.26, while uncertainty declined from 41.9 to 37.2 and qa_evasiveness declined from 42.3 to 37.8. That is a useful pattern: management was more confident in the discussion and less evasive, but less exuberant on guidance. In other words, the call did not try to paper over the EPS miss with indiscriminate optimism. It gave investors a cleaner split between defensible current facts and more cautious forward framing.

That tonal split also helps reconcile the conflicting signals in the numbers: Q2 FY2026 EPS of ¥19.56 was far below the street’s ¥32.01, but first-half operating cash flow was cited at ¥93.2 billion, about ¥11.5 billion higher than the first half of 2024, and management announced a new share buyback program of ¥80 billion with the acquisition period starting from December 1 and until November 2026 in addition to the ¥100 billion share buyback announced on May 8. Those capital-return numbers do not erase the -38.9% EPS surprise, but they reduce the probability that management views the miss as a balance-sheet event. The buyback timing matters: December 1 comes after this Q2 FY2026 print, so the company is willing to lean into shareholder returns after the quarter investors are most likely to punish. The cash balance comment that it will shrink to ¥900 billion gives the market a level to audit against, although the pack does not give the starting cash balance needed to judge the pace of that reduction.

The food-cycle risks are still real, and they are the main reason not to ignore the EPS miss. Management said consumer frugality increased and the second quarter was affected by extremely hot weather; those qualitative explanations are only usable because the numbers underneath show Japan first-half volume at 94% despite unit price at 113%, and Japanese Food Products excluding coffee volume at 99% despite unit price at 102%. The rice shortage also created some decline in sales and profit, though the excerpt does not quantify that decline. Coffee is a partial offset: in the first half alone, compared to the previous year, more than ¥1 billion profit increase was recorded. But a portfolio manager should not pay a semiconductor multiple for price-taking food volume. The defensible investment case is narrower: own the name if you believe Functional Materials 120% first-half sales and business-profit growth and the 70% to more than 85% internal-sales strategy by 2030 will matter more to incremental earnings power than domestic food volume at 94%.

The next quarter will decide whether this print is an entry point or a value trap, and the confirmation levels are concrete. For Q3 FY2026, the history line shows revenue of ¥425,287.0 million, gross margin of 39.0%, revenue QoQ of +13.4%, revenue YoY of +4.5%, and diluted EPS of ¥39.64; the thesis needs the company to validate that kind of seasonal and mix recovery, not merely repeat Q2 FY2026 revenue of ¥374,873.0 million and EPS of ¥19.56. The break point is a gross margin back toward Q4 FY2025’s 33.9% without a clear explanation from food mix or one-time factors, because the whole argument depends on Q2 FY2026’s 37.5% margin being a sign of structural mix rather than temporary accounting relief. On the semiconductor side, the next call needs to preserve the first-half Functional Materials message that sales and business profit were 120% of prior-year levels, and investors should listen for any change in the internal-sales target of 70% rising to more than 85% by 2030. On capital allocation, the dates are May 8 for the ¥100 billion buyback already announced and December 1 through November 2026 for the ¥80 billion program; slippage there would weaken the claim that management sees the miss as contained. If Q3 FY2026 delivers revenue near ¥425,287.0 million, gross margin near 39.0%, and EPS near ¥39.64 while Functional Materials still tracks the logic IC growth discussion around plus 23.9% and close to 20% growth, the market’s initial focus on the -4.5% revenue surprise and -38.9% EPS surprise will have been too blunt.